胫骨骨折--扩髓和不扩髓髓内钉比较

关于这个主题的文献质量不高，因此很难得出一个结论，究竟是扩髓钉还是不扩髓钉的效果更好。这个报告提示：对于开放或闭合性胫骨骨折，两种治疗方法在骨愈合率和并发症上没有统计学差异，建议对患者的功能和生活质量进行更深入和详细的评价和分析研究。     

Development of quality indicators: lessons learned in bariatric surgery

Quality indicators will likely be used in comprehensive surgical quality assessment and improvement programs. Quality indicators are the actions equated with good quality of care. As a case example, bariatric surgery quality indicators were developed using evidence in the literature combined with formal expert opinion validation. Qualitative analysis was performed to identify the critical thematic issues surrounding development of these surgical quality indicators. Researchers identified five major thematic categories during the development process. These included feasibility in medical records (availability, ease of abstraction, and cost), the number of indicators developed (optimal number), the lack of evidence in the literature (weight on expert opinion), structural versus process indicators, and linkage to outcomes (need to demonstrate that adherence to indicators is associated with better outcomes). This project, using bariatric surgery as an example, uncovered important issues that need to be addressed when developing quality assessment and quality improvement programs for evaluating surgical quality. As quality indicators will likely be developed and used increasingly, future projects in this regard will benefit from these lessons.     

Improving quality of recovery: what anaesthetic techniques make a difference?

Practising evidence-based medicine in anaesthesia can be difficult. Minor, transient complications are common after anaesthesia and surgery and these may or may not have a significant effect on patient outcome, including overall quality of recovery. Most anaesthesia research does not provide reliable information about effective interventions. Nevertheless, good quality evidence from randomized trials and systematic reviews is available, and their uptake into clinical practice should reduce serious or permanent complications. Most patients do not suffer major complications and so their quality of recovery needs to be defined in other ways and this should be assessed from the patient's perspective. Thus, a good outcome can be defined by avoidance of major complications and the experience of a good quality recovery. Changes in clinical practice should be evidence-based and this requires the conduct of good quality clinical research, including large trials. This paper identifies some anaesthetic techniques that do make a difference; these should be part of routine practice.     

Clinical audit,quality improvement and data quality

Clinical audit and quality improvement are essential processes that help to ensure that patients receive safe, effective, and high-quality care. By participating in clinical audit and quality improvement initiatives, anaesthetists can gain a deeper understanding of the care provided to patients and identify areas for improvement. Ensuring good data quality is crucial for these processes, and can be achieved by following a systematic approach to data management, including training on data collection and management techniques, strict data validation procedures and regular data quality checks. Additionally, involving patients, staff, and other stakeholders in the process can help to ensure that changes are well received and implemented effectively. By participating in these processes, we can contribute to the ongoing efforts to improve the quality of care provided by the NHS, and develop the skills and knowledge necessary for continuing professional development.     

Surgical prophylaxis and other complication avoidance care bundles

Individual health care quality measures that have been shown to improve outcome can be combined together into what are called care bundles, with the expectation that this set of practices produces further improvements in outcome. Prevention of surgical site infection is the focus of several quality measures put forward by the Surgical Care Improvement Project; these can collectively be considered a bundle as well. Whether these process measures, which include several components related to the administration of antibiotic prophylaxis, are effective in decreasing rates of surgical site infection has come under considerable debate recently.     

Novel Raman Spectroscopic Biomarkers Indicate That Postyield Damage Denatures Bone's Collagen

Raman spectroscopy has become a powerful tool in the assessment of bone quality. However, the use of Raman spectroscopy to assess collagen quality in bone is less established than mineral quality. Because postyield mechanical properties of bone are mostly determined by collagen rather than the mineral phase, it is essential to identify new spectroscopic biomarkers that help infer the status of collagen quality. Amide I and amide III bands are uniquely useful for collagen conformational analysis. Thus, the first aim of this work was to identify the regions of amide bands that are sensitive to thermally induced denaturation. Collagen sheets and bone were thermally denatured to identify spectral measures that change significantly following denaturation. The second aim was to assess whether mechanical damage denatures the collagen phase of bone, as reflected by the molecular spectroscopic biomarkers identified in the first aim. The third aim was to assess the correlation between these new spectroscopic biomarkers and postyield mechanical properties of cortical bone. Our results revealed five peaks whose intensities were sensitive to thermal and mechanical denaturation: ～1245, ～1270, and ～1320 cm^–1 in the amide III band, and ～1640 and ～1670 cm^–1 in the amide I band. Four peak intensity ratios derived from these peaks were found to be sensitive to denaturation: 1670/1640, 1320/1454, 1245/1270, and 1245/1454. Among these four spectral biomarkers, only 1670/1640 displayed significant correlation with all postyield mechanical properties. The overall results showed that these peak intensity ratios can be used as novel spectroscopic biomarkers to assess collagen quality and integrity. The changes in these ratios with denaturation may reflect alterations in the collagen secondary structure, specifically a transition from ordered to less‐ordered structure. The overall results clearly demonstrate that this new spectral information, specifically the ratio of 1670/1640, can be used to understand the involvement of collagen quality in the fragility of bone. © 2015 American Society for Bone and Mineral Research.     

New laboratory tools in the assessment of bone quality

Bone quality is a complex set of intricated and interdependent factors that influence bone strength. A number of methods have emerged to measure bone quality, taking into account the organic or the mineral phase of the bone matrix, in the laboratory. Bone quality is a complex set of different factors that are interdependent. The bone matrix organization can be described at five different levels of anatomical organization: nature (organic and mineral), texture (woven or lamellar), structure (osteons in the cortices and arch-like packets in trabecular bone), microarchitecture, and macroarchitecture. Any change in one of these levels can alter bone quality. An altered bone remodeling can affect bone quality by influencing one or more of these factors. We have reviewed here the main methods that can be used in the laboratory to explore bone quality on bone samples. Bone remodeling can be evaluated by histomorphometry; microarchitecture is explored in 2D on histological sections and in 3D by microCT or synchrotron. Microradiography and scanning electron microscopy in the backscattered electron mode can measure the mineral distribution; Raman and Fourier-transformed infra-red spectroscopy and imaging can simultaneously explore the organic and mineral phase of the matrix on multispectral images; scanning acoustic microscopy and nanoindentation provide biomechanical information on individual trabeculae. Finally, some histological methods (polarization, surface staining, fluorescence, osteocyte staining) may also be of interest in the understanding of quality as a component of bone fragility. A growing number of laboratory techniques are now available. Some of them have been described many years ago and can find a new youth; others having benefited from improvements in physical and computer techniques are now available.     

Quality of life in end-stage renal disease: a reexamination

A self-administered questionnaire assessing both objective and subjective quality of life was completed by 489 end-stage renal disease (ESRD) patients in a representative sample of an entire network. Patients differed in both objective and subjective quality of life when examined as a function of treatment modality. The quality of life is similar for successful transplant and home hemodialysis patients; these patients appear to fare better than other treatment groups on both objective and subjective measures. Patients receiving staff-assisted center hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) report markedly diminished quality of life; these decrements remained after statistically controlling for nontreatment variables. Diminished quality of life was most pronounced in dialysis patients who had experienced failed transplants. All treatment groups showed some objective losses, especially loss of employment, but patients in the best rehabilitated treatment groups showed near-normal subjective quality of life. The results confirm previous reports that the subjective quality of life of ESRD patients can be nearly normal despite objective losses, but demonstrate that inadequate definition of treatment groups has led to misperceptions about the impact of transplant failure.     

Utility of Ecological Risk Factors for Evaluation of Transplant Center Performance

There is substantial evidence across different healthcare contexts that social determinants of health are strongly associated with morbidity and mortality in the United States. These factors, including socioeconomic status, behavior and environmental risks, education, social support, healthy food, and access to healthcare also vary widely by region and individual communities. One of the implications of heterogeneity in these risks is the potential impact on measured quality of healthcare providers. In particular, there is concern that providers treating disproportionally vulnerable communities may be disadvantaged by lack of risk adjustment for these factors that affect health but not indicators of quality of care. Recently, the National Quality Forum has endorsed risk adjustment for sociodemographic characteristics based on these concerns. These issues are salient to transplant programs since social determinants of health impact transplant patient outcomes and vary by region. In this viewpoint, we argue that integration of ecological (area‐level) factors in risk adjustment models used to assess transplant center quality should be strongly considered. We believe this reform could be accomplished rapidly, would attenuate disparities in access to care by reducing disincentives to treat patients from vulnerable communities, and improve risk adjustment and calibration of models used for center evaluations.     

Quality of Life of Patients with Advanced Chronic Kidney Disease Receiving Conservative Care without Dialysis

With the evidence that dialysis may not necessarily be beneficial for older adults with advanced chronic kidney disease (CKD), there is a growing interest in promoting conservative care without dialysis as a viable treatment option for these individuals. This review summarizes the current empirical evidence of symptom experiences and quality of life of patients receiving conservative care. Data suggest that conservative care may yield symptom experiences and quality of life that are compatible with those of patients on dialysis. However, these data are exclusively from studies conducted outside of the United States in which there were often no comparison groups or study designs that could provide high quality evidence. There is an urgent need for further research and developing a conservative care model suitable for CKD populations in the U.S.     

Quality of life following prostate cancer treatments

Quality of life is of major concern to patients when choosing a treatment for prostate cancer. Health-related quality of life (HRQOL) is a patient-centered variable from the field of health services research that can be assessed in a valid and reliable manner. Using standardized questionnaires specifically designed to measure HRQOL in men with prostate cancer, we can now study the effect of various treatments on patients’ quality of life. Treatments for metastatic prostate cancer can have significant effects in all areas of patients’ quality of life. Patients with localized disease undergoing radical prostatectomy (RP) tend to have more sexual and urinary dysfunction than do men undergoing external beam radiation therapy (EBRT), although both groups have worse quality of life in these areas than age-matched controls. Men undergoing EBRT have worse bowel function than age-matched controls or men undergoing RP. Recent studies of men undergoing interstitial brachytherapy indicate that these patients have less urinary leakage than those who undergo RP, but experience considerably more irritative voiding symptoms, which can profoundly affect quality of life. Patients need to be informed of the possible impact of therapy on quality of life when choosing treatment.     

Quality of life and severity of symptoms in gastro-oesophageal reflux disease: a clinical review.

My purpose is to review the quality of life (QoL) instruments used in the assessment of gastro-oesophageal reflux disease (GORD) and assess the effects of GORD on quality of life. Many instruments have been used in the assessment of quality of life in patients with GORD, and these have varied both in quality and purpose. In general, the choice of instrument depends on its purpose. Several investigators, using generic quality of life instruments, have shown that GORD significantly reduces QoL, and its effects are comparable with those of congestive heart failure. However, these generic instruments do not seem to be sensitive enough to measure the effects of treatments on GORD. For this, disease-specific instruments are more appropriate. Both medical and surgical treatment has been shown to improve QoL. The choice of instrument is entirely dependent on the investigator's reason for measuring QoL in GORD patients.     

Quality of life after treatment for prostate cancer

Quality of life is a major concern of patients when they are choosing treatment for prostate cancer. Health-related quality of life is a patient-centered variable from the field of health services research that can be measured in a valid and reliable manner. Using standardized questionnaires specifically developed to capture health-related quality of life data in men with prostate cancer, the effect of treatments on patients’ quality of life can be studied. Patients with localized disease who are undergoing radical prostatectomy tend to have more sexual and urinary dysfunction than men undergoing external beam radiation therapy, although both groups have more impairment in these areas than agematched controls. Men undergoing external beam radiation therapy have worse bowel function and more urinary distress from irritative voiding symptoms than men undergoing radical prostatectomy or age-matched controls. Recent studies of men undergoing interstitial brachytherapy indicate that these patients have less urinary leakage than those who undergo radical prostatectomy, but experience considerably more irritating voiding symptoms, which often profoundly affect their quality of life. Better information regarding the potential impact of prostate cancer treatment on quality of life will improve medical decision-making.     

Long-term function and quality of life after esophageal resection for cancer and Barrett's

Esophagectomy is the treatment of choice for cancer or high-grade dysplasia. Although the patients frequently experience symptoms postoperatively, their quality of life is most often comparable to that of a control population. This article provides details of post-esophagectomy symptomatology and examines how quality of life can be measured in these patients.     

Appraising the Quality of Care in Surgery

There is currently no validated measurement system available for quality of care assessment in surgery despite all of the inherent benefits of such an approach. A structured quality framework needs to be developed and incorporate measures that are truly reflective of several important dimensions of care within the entire treatment episode. Presently this has been only partially addressed. These measures of quality can be categorized into clinical pathway measures (structure of care, process of care, outcome of care, and economic measures of care) and patient-reported measures (patient-reported treatment outcomes, health-related quality of life measures, and patient satisfaction). Combining these measures to create an overall composite quality score can be made feasible only if it is supported by the use of robust statistical methodology. It is important to use appropriate display of performance data to facilitate provider engagement in quality improvement initiatives. This article was designed to present such a structured approach of a quality framework, which is required to appraise the quality of care in surgery to enhance future quality improvement programmes.     

B vitamins, homocysteine, and bone disease: Epidemiology and pathophysiology

Observational studies indicate that mildly elevated homocysteine is a strong risk factor for osteoporotic fracture, yet there is no clear biologic mechanism for an effect of homocysteine on bone. The association could instead be attributed to B vitamins (folate, vitamin B(12), vitamin B(6)), as low levels of these nutrients are the primary determinants of homocysteine and may be associated with lower bone quality. Discovery of a direct effect of homocysteine or B vitamins on bone would be important in terms of interventions, as these factors can be modified with changes in diet or supplementation. This article reviews the connections of homocysteine and B vitamins to measures of bone quality and osteoporotic fracture. Although the literature suggests that these factors may be associated with bone health, most of the epidemiologic studies are observational, limiting conclusions regarding causality. More controlled -trials are needed to determine whether treatment with B vitamins would reduce fracture rates among community-dwelling cohorts.     

What makes a measurement instrument valid and reliable?

High quality instruments are useful tools for clinical and research purposes. To determine whether an instrument has high quality, measurement properties such as reliability and validity need to be assessed, using standardised criteria. This paper discusses these quality domains and measurement properties using the standardised criteria that were recently published by the COSMIN group. Examples are given of studies evaluating the measurement properties of instruments frequently used in trauma. This paper presents a helpful tool for readers who want to evaluate or assess the quality of a measurement instrument on reliability and validity.     

Evaluation of neuro-oncology information for French speaking patients on the Internet

OBJECTIVE: Internet has become the first place where patients go to when seeking information about their disease. Little is known about the type and the quality of the medical information available on French-speaking websites, especially in the field of neuro-oncology. The purpose of this study was to evaluate the quality of these sites. MATERIALS AND METHODS: We entered six key words "glioblastome", "méningiome", "métastase cérébrale", "neurinome de l'acoustique", "adénome à prolactine" and "lymphome primitif cérébral" into 2 different search engines and, for each key word, the first fifty websites were reviewed using the tool "DISCERN", and with the help of two neuro-oncologists, we rated their content in terms of quality and comprehension. RESULTS: On 612 websites only 110 (18%) contained information that proved to be somewhat useful to patients. The average score for quality was 32, which is considered to be . According to our scoring system, 1.8% of websites were found to be "excellent", 11.8% "good", 24.5% "fairly good", 15.4% "average", 32.7% "poor" and 13.6% "very poor". Just over 50% of the websites were found to be clear. The study also showed that the order in which these websites were ranked in the search engine, their affiliation, their target or who financed them had little impact on quality. The websites were more likely to be of high quality if they were managed by doctors and had bibliographical references as well as a date indicating a recent website's update. DISCUSSION AND CONCLUSION: This study shows that the search for medical information on the Internet is time consuming and often disappointing: very few websites provide information that is both clear and exhaustive. However, we also found that very few websites contained information that was seriously inaccurate. Given the growing popularity of the Internet, patients could certainly benefit from a high quality French speaking website that would specialize in cerebral tumors, as well as from a neuro-oncological portal that would take them to selected websites as it would save time and would be a guarantee for quality.     

Ergebnisqualität in der Unfallchirurgie

Trauma surgery and orthopedic trauma surgery have been accompanied not only by internal quality assessment, but also by external quality assessment procedures right from the beginning. The reasons for these mechanisms were based on legal regulations of treatment of work-related accidents. In 1958, the Arbeitsgemeinschaft für Osteosynthese (Working Group on Osteosynthesis, AO group) was founded. The results of the AO's scientific activities built the basis of osteosyntheses. In 1988, legal regulations changed again in Germany. Since this reform of some important facets of public health care, each hospital or institution is committed to perform external and internal quality assessment. In addition, the introduction of a payment system based on diagnosis-related groups makes it necessary to install basic quality management systems within the next few years. This paper presents some well-established procedures, especially the diagnosis-related study in the whole district of Westphalia-Lippe. The aim of the study was a quality assessment of the treatment of intracapsular fractures of the collum of the femur. Problems in data analysis and interpretation are shown. Because of some grave problems, certain changes in the study design seem to be warranted. Despite these facts, however, we are convinced that we not only need this kind of quality assessment, but that we should try to expand these studies based on the experiences we gained.     

An evidence-based evaluation of intradialytic parenteral nutrition

Malnutrition is a well-recognized comorbid condition in dialysis patients that contributes to the increased mortality seen in these patients. Multiple interventions have been tried in an effort to decrease mortality. The most controversial of these is intradialytic parenteral nutrition. In an era of high costs and shrinking budgets, it is important to critically examine published data to determine the quality of the data and to determine whether the reported results are valid and clinically applicable. Using an evidence-based approach, all published literature concerning intradialytic parenteral nutrition was reviewed, quality of the data determined, number needed to treat (NNT) calculated, and potential costs of treatment determined. Twenty-four studies that met the search criteria were identified. Only three studies were randomized; one of these was a feasibility study, and the other two were only of level B quality. The remaining studies were either case reports or observational studies of level C quality. The absolute risk reduction in mortality with intradialytic parenteral nutrition (IDPN) usage ranged from 0.12 to 0.65; relative risk reduction ranged from 0.48 to 0.74; NNT ranged from 2 to 17; cost ranged from $150,000,000 to $877,500,000; and 588 to 9,750 patients might be expected to experience a decrease in mortality. The results of this review indicate that the data supporting the use of IDPN are weak and a clear recommendation cannot be made. IDPN use in hemodialysis patients seems to be associated with decreased mortality. IDPN should be available for use in patients who meet previously published guidelines and who are not normoalbuminemic.